103 results on '"Brossart P"'
Search Results
2. The German Network for Personalized Medicine to enhance patient care and translational research
3. AB1527 TELEDIDACTIC MUSCULOSKELETAL ULTRASOUND COURSE AND COMPARISON WITH CONVENTIONAL ON-CAMPUS TRAINING – INTERIM ANALYSIS OF THE TELMUS STUDY
4. POS0724 TRANSORBITAL ULTRASOUND IN NEWLY DIAGNOSED GIANT CELL ARTERITIS – A PROSPECTIVE STUDY
5. AB0380 PREVALENCE OF SLEEP-RELATED BREATHING DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND PERIPHERAL SPONDYLOARTHRITIS
6. AB0361 BONN PULSA: PULMONARY SCREENING IN ARTHRITIS - PREVALENCE OF PULMONARY MANIFESTATIONS IN PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND PERIPHERAL SPONDYLOARTHRITIS
7. AB1166 RANDOMIZED CONTROLLED TRIAL TO ANALYSE THE EFFECT OF BLOOD FLOW RESTRICTION TRAINING IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS COMPARED TO CONVENTIONAL RESISTANCE TRAINING – AN INTERIM ANALYSIS
8. POS0916 THE CURRENT SITUATION OF MUSCULOSKELETAL ULTRASOUND EDUCATION - A SYSTEMATIC LITERATURE REVIEW
9. AB0137 FIRST-IN-HUMAN INVESTIGATION OF HYDROGEN VOLTAGE-GATED CHANNEL 1 (HVCN1) EXPRESSION AND LEVELS OF MYELOPEROXIDASE AND OXIDIZED DNA (8-OHDG) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLEOX STUDY) – AN INTERIM ANALYSIS
10. 707TiP Postoperative adjuvant radiochemotherapy (aRCH) with cisplatin versus aRCH with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma: The ADRISK trial
11. In the phase III IMmotion151 trial of metastatic renal cell carcinoma the easy-to-implement modified Glasgow prognostic score predicts outcome more accurately than the IMDC score
12. 1028P BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response – results from the NSCLC cohort
13. OP0029 PROSPECTIVE, DOUBLE-BLIND STUDY ON THE VALUE OF HANDHELD MUSCULOSKELETAL ULTRASOUND PERFORMED BY DERMATOLOGISTS FOR DETECTION OF PSORIATIC ARTHRITIS - THE PsoSone STUDY
14. POS1387 ULTRASOUND FINDINGS OF JOINTS AND ENTHESES FOLLOWING ONE HOUR OF AGE AND GENDER ADJUSTED WEIGHT TRAINING
15. Prevalence of joint, entheseal, tendon, and bursal findings in young, healthy individuals by musculoskeletal ultrasound
16. AB0152 PROSPECTIVE ANALYSIS OF OBSTRUCTIVE SLEEP APNEA IN NEWLY DIAGNOSED PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND PERIPHERAL SPONDYLOARTHRITIS – A SCREENING STUDY
17. POS1271 PREVALENCE OF JOINT EFFUSION, HYPERPERFUSION AND ENTHESITIS IN YOUNG HEALTHY INDIVIDUALS
18. POS1126 PREVALENCE OF HYPOPHOSPHATASIA IN ADULT RHEUMATOLOGY PATIENTS SCREENED BY LOW LEVELS OF ALKALINE PHOSPHATASE
19. AB0847 ESTABLISHMENT AND VALIDATION OF A DIDACTIC MUSCULOSKELETAL ULTRASOUND COURSE FOR DERMATOLOGISTS USING AN INNOVATIVE HANDHELD ULTRASOUND SYSTEM – THE MUDE STUDY (MUSCULOSKELETAL ULTRASOUND IN DERMATOLOGY)
20. AB0846 CONCEPTION AND FEASIBILITY OF A DIGITAL TELE-GUIDED ABDOMEN, THORAX AND THYROID GLAND ULTRASOUND COURSE FOR MEDICAL STUDENTS
21. OP0151 AUTOANTIBODIES AGAINST DENSE-FINE-SPECKLED 70 (DFS70) DO NOT ENTIRELY EXCLUDE CONNECTIVE TISSUE DISEASES
22. Prävalenz der Hypophosphatasie bei adulten Patienten in der Rheumatologie
23. Parameters predicting COVID-19-induced myocardial injury and mortality
24. 749P Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC): Extended follow-up from CheckMate 032
25. FRI0548 PREVALENCE AND THERAPY OF RHEUMATOLOGICAL ADVERSE EVENTS DUE TO IMMUNE CHECKPOINT INHIBITOR THERAPY
26. OP0147 MEASUREMENT OF FLOW VELOCITIES OF THE CENTRAL RETINAL ARTERY IN PATIENTS WITH GIANT CELL ARTERITIS WITH VISUAL SYMPTOMS AND CONTROLS
27. OP0318 THE ROLE OF DUAL ENERGY COMPUTED TOMOGRAPHY (DECT) IN THE DIFFERENTIATION OF GOUT AND CALCIUM PYROPHOSPHATE DEPOSITION DISEASE
28. AB0465 ANALYSIS OF VASCULITIS PATTERNS IN PATIENTS WITH GIANT CELL ARTERITIS COMPARED TO PATIENTS WITH GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA
29. SAT0254 PROSPECTIVE ANALYSIS OF THE PREVALENCE OF GIANT CELL ARTERITIS IN CONSECUTIVE PATIENTS WITH POLYMYALGIA RHEUMATICA
30. Ex Vivo Manipulation of Peripheral Blood CD34+ Cells
31. Interleukin-2-Based Immunotherapy and Chemoimmunotherapy in Metastatic Melanoma
32. OA15.05 BIOLUMA: A Phase II Trial of Nivolumab and Ipilimumab in Lung Cancer – Prospective Evaluation of TMB in SCLC Patients
33. PF597 HIGH DOSE MELPHALAN (200MG/M2) AND AUTOLOGOUS TRANSPLANTATION IN NEWLY-DIAGNOSED MULTIPLE MYELOMA UP TO THE AGE OF 70 YEARS: A SUBGROUP ANALYSIS FROM THE PHASE III GMMG-MM5 TRIAL
34. Antibiotic resistant bacteria and resistance genes in biofilms in clinical wastewater networks
35. The occurrence of antimicrobial substances in toilet, sink and shower drainpipes of clinical units: A neglected source of antibiotic residues
36. Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1 mg/kg + ipilimumab 3 mg/kg expansion from CheckMate 032
37. Vascular expression of prostate-specific membrane antigen in renal tumors: Diagnostic and prognostic role
38. Evaluation of dose intensification of cytarabine in postremission therapy in older AML patients within the prospective phase II AMLSG 06-04 study
39. Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial
40. MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation
41. In vivo and In vitro Identification of Endocannabinoid Signaling in Periodontal Tissues and Their Potential Role in Local Pathophysiology
42. Progressive Verhärtung der Haut mit derben Papeln
43. Karzinoide der Lunge
44. Successful treatment of refractory leiomyosarcoma with the PD-1 inhibitor nivolumab
45. Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial
46. γ-Glutamyl-Transferase ist ein unabhängiger Biomarker für splanchnische Thrombosen bei Patienten mit myeloproliferativen Neoplasien
47. Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
48. Development of Hemolytic Anemia in a Nivolumab-Treated Patient with Refractory Metastatic Squamous Cell Skin Cancer and Chronic Lymphatic Leukemia
49. The JAK inhibitor ruxolitinib impairs dendritic cell migration via off-target inhibition of ROCK
50. Exanthem subitum (human herpesvirus‐6 reactivation) after autologous stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.